Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast.

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

The US election failed to deliver extra Chinese stimulus measures companies had been banking on, affecting copper and iron ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

ASX 200 drops as gold, iron ore and energy stocks struggle Paladin shares plunge after cutting uranium output forecast ...

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for crypto, says US billionaire ...

The ASX dipped again as mining and energy stocks fell, with Paladin Energy slashing its guidance and seeing shares drop more ...

MA Moelis rates Carnaby a Buy with a high target, while RBC gives FireFly an Outperform rating on its Green Bay project.

Bitcoin tops record with bets on $100K by December, amid rumours of a nation-state quietly buying Bitcoin and US Bitcoin ...

Stockhead’s Sarah Hughan sits down with Great Southern Mining (ASX:GSN) managing director Matt Keane to get the short end of ...

Suvo aims to cut emissions in cement production with its green solution, targeting a potential trillion-dollar market.

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...